SDS

Bayer Environmental Science
SAFETY DATA SHEET
BAYER ADVANCED DISEASE CONTROL FOR ROSES,
FLOWERS & SHRUBS CONCENTRATE
7/10
Version 3.0 / USA Revision Date: 05/18/2015
102000012168
Print Date: 05/19/2015
SECTION 11: TOXICOLOGICAL INFORMATION
Exposure routes
Ingestion, Inhalation, Eye contact, Skin Absorption
Immediate Effects
Skin
Harmful if absorbed through skin. May cause slight irritation.
Ingestion
Harmful if swallowed.
Inhalation
Harmful if inhaled.
Information on toxicological effects
Acute oral toxicity
LD50 (male/female combined rat) > 2,000 mg/kg
Acute inhalation toxicity
LC50 (male/female combined rat) > 1.975 mg/l
Exposure time: 4 h
Determined in the form of liquid aerosol.
LC50 (male/female combined rat) > 7.9 mg/l
Exposure time: 1 h
Determined in the form of liquid aerosol.
Extrapolated from the 4 hr LC50.
Acute dermal toxicity
LD50 (male/female combined rat) > 4,000 mg/kg
Skin irritation
Slight irritation (rabbit)
Eye irritation
No eye irritation (rabbit)
Sensitisation
Non-sensitizing. (guinea pig)
Assessment repeated dose toxicity
Tebuconazole did not cause specific target organ toxicity in experimental animal studies.
Assessment mutagenicity
Tebuconazole was not mutagenic or genotoxic in a battery of in vitro and in vivo tests.
Assessment carcinogenicity
Tebuconazole caused at high dose levels an increased incidence of tumours in mice in the following
organ(s): liver. The mechanism of tumour formation is not considered to be relevant to man.
ACGIH
None.
NTP
None.
IARC
None.
OSHA
None.